Guardant Health announced an almost $100M Series D round for its cancer blood test
The Redwood City, Calif.-based company has raised nearly $100 million in Series D financing led by OrbiMed Advisors.
GuardantHealth, Flatiron Health to link genomics, analytics for personalized cancer care
In a further sign of the convergence happening in healthcare technology, genomics company GuardantHealth is teaming with health IT and analytics vendor Flatiron Health to create a new platform to enable personalized cancer care.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.